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Abstract Long lasting pyrethroid treated bednets are the most important tool for preventing
malaria. Pyrethroid resistant Anopheline mosquitoes are now ubiquitous in Africa, though the
public health impact remains unclear, impeding the deployment of more expensive nets. Meta-
analyses of bioassay studies and experimental hut trials are used to characterise how pyrethroid
resistance changes the efficacy of standard bednets, and those containing the synergist piperonyl
butoxide (PBO), and assess its impact on malaria control. New bednets provide substantial
personal protection until high levels of resistance, though protection may wane faster against more
resistant mosquito populations as nets age. Transmission dynamics models indicate that even low
levels of resistance would increase the incidence of malaria due to reduced mosquito mortality and
lower overall community protection over the life-time of the net. Switching to PBO bednets could
avert up to 0.5 clinical cases per person per year in some resistance scenarios.
DOI: 10.7554/eLife.16090.001
Introduction
It is estimated that 68% of the 663 million cases of malaria that have been prevented since the year
2000 have been through the use of long-lasting insecticide treated bednets (LLINs) (Bhatt et al.,
2015). However, there is a growing realisation that insecticide resistance is putting these advances
under threat (WHO, 2012), with mosquitoes reporting widespread resistance to pyrethroids, the
only class of insecticides currently approved for use in bednets (Ranson and Lissenden, 2016). The
public health impact of pyrethroid resistance in areas of LLIN use is hard to quantify as a comparison
between sites is complicated by multiple epidemiological factors making it difficult to ascribe differ-
ences in malaria metrics solely to mosquito susceptibility (Kleinschmidt et al., 2015). The efficacy of
LLINs against mosquitoes is typically measured in experimental hut trials (WHO, 2013a). These
experiments are time consuming, relatively expensive, and geographically limited and by themselves
they do not fully account for all effects of the LLIN as they do not show the community impact (herd
effects) caused by the insecticide killing mosquitoes (Killeen et al., 2007; Magesa et al., 1991).
Mathematical models can be used to translate entomological endpoint trial data into predictions of
public health impact. Currently this has only been done for a small number of sites (Brie¨t et al.,
2013) making it difficult for malaria control programmes to understand the problems caused by
insecticide resistance in their epidemiological setting.
There are no easy to use genetic markers that can reliably predict the susceptibility of mosquitoes
to pyrethroid insecticide (Weetman and Donnelly, 2015). The current most practical phenotypic
method for assessing resistance is the use of bioassays which take wild mosquitoes and measures
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their mortality after exposure to a fixed dose of insecticide (WHO, 2013a). However the discriminat-
ing doses used in the assay are unrelated to the field exposure and so the predictive value of these
bioassays for assessing the problems of pyrethroid resistance is unknown. A meta-analysis has shown
that insecticide treated bednets still outperform untreated nets in experimental hut trials even
against pyrethroid resistant populations (Strode et al., 2014) though the community impact (herd
effects) of the LLIN was not assessed (Killeen et al., 2007). The population prevalence of pyrethroid
resistance is known to be changing at a fast rate (Toe´ et al., 2014) making it important to regularly
re-evaluate the efficacy of LLINs in order to guide current vector control and resistance management
strategies (WHO, 2012).
There are limited tools available for tackling pyrethroid resistance and protecting the advances
made in malaria control. Until new LLINs containing alternative insecticide are available the only
alternative bednet are those containing pyrethroids plus the insecticide synergist piperonyl butoxide
(PBO). Studies have shown that PBO LLINs are substantially better at killing insecticide resistant mos-
quitoes in some locations but not others (Ngufor et al., 2014a, 2014b; Kitau et al., 2014;
Asale et al., 2014; Ngufor et al., 2014c; Koudou et al., 2011; Corbel et al., 2010; Tungu et al.,
2010; Malima et al., 2008; Adeogun et al., 2012a; Agossa et al., 2014; Malima et al., 2013). PBO
LLINs are more expensive than standard LLINs, with one manufacturer’s 2012 price for PBO LLIN
being US$4.90 compared to a comparable standard LLIN price of US$3.25 (Brie¨t et al., 2013). This
makes it unclear where and when their use would be beneficial over standard LLINs given con-
strained public health budgets. A mathematical modelling study used results from 6 experimental
hut trials comparing a standard LLIN (PermaNet 2.0) with a PBO LLIN (PermaNet 3.0) against Anoph-
eles gambiae sensu lato mosquitoes (Brie¨t et al., 2013). It predicted that the more expensive PBO
LLIN was still cost effective compared to a threshold of US$150/DALY averted (not comparing
against standard LLINs) in 4 of the 6 sites, though these results are not generalisable beyond the
eLife digest In recent years, widespread use of insecticide-treated bednets has prevented
hundreds of thousands cases of malaria in Africa. Insecticide-treated bednets protect people in two
ways: they provide a physical barrier that prevents the insects from biting and the insecticide kills
mosquitos that come into contact with the net while trying to bite. Unfortunately, some mosquitoes
in Africa are evolving so that they can survive contact with the insecticide currently used on bednets.
How this emerging insecticide resistance is changing the number of malaria infections in Africa is
not yet clear and it is difficult for scientists to study. To help mitigate the effects of insecticide
resistance, scientists are testing new strategies to boost the effects of bednets, such as adding a
second chemical that makes the insecticide on bednets more deadly to mosquitoes. In some places,
adding this second chemical makes the nets more effective, but in others it does not. Moreover,
these doubly treated, or “combination”, nets are more expensive and so it can be hard for health
officials to decide whether and where to use them.
Now, Churcher et al. have used computer modeling to help predict how insecticide resistance
might change malaria infection rates and help determine when it makes sense to switch to the
combination net. Insecticide-treated bednets provide good protection for individuals sleeping under
them until relatively high levels of resistance are achieved, as measured using a simple test. As more
resistant mosquitos survive encounters with the nets, the likelihood of being bitten before bed or
while sleeping unprotected by a net increases. This is expected to increase malaria infections. As
bednets age and are washed multiple times, they lose some of their insecticide and this problem
becomes worse.
Churcher et al. also show that the combination bednets may provide some additional protection
against resistant mosquitos and reduce the number of malaria infections in some cases. The
experiments show a simple test could help health officials determine which type of net would be
most beneficial. The experiments and the model Churcher et al. created also may help scientists
studying how to prevent increased spread of malaria in communities where mosquitos are becoming
resistant to insecticide-treated nets.
DOI: 10.7554/eLife.16090.002
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specific sites chosen by the manufacturer, population prevalence of resistance, the type of LLIN or
mosquito species. The WHO has recognised the increased bio-efficacy of PermaNet 3.0 in some
areas (WHO, 2015) but there is a lack of clear consensus on when and where these should be
deployed. Defining the added public health benefit expected by a switch to PBO LLINs is essential
to guide decisions on pricing, purchasing and deployment.
Here we propose that information on the current malaria endemicity, mosquito species and popu-
lation prevalence of pyrethroid resistance (as measured by bioassay mortality) can be used to predict
the public health impact of pyrethroid resistance and choosing the most appropriate LLIN for the
epidemiological setting. Firstly (1) a meta-analysis and statistical model are used to determine
whether mosquito mortality in a bioassay can be used to predict the proportion of mosquitoes,
which die in experimental hut trials and to define the shape of this relationship. Secondly (2), another
meta-analysis of experimental hut trial data is analysed to characterise the full impact of pyrethroid
resistance on LLIN effectiveness. Thirdly, information from (1) and (2) is used to parameterise a
widely used malaria transmission dynamics mathematical model to estimate the public health impact
of pyrethroid resistance in different settings taking into account the community impact of LLINs. An
illustration of model predictions showing how different malaria metrics change over time is given in
Figure 1. Scenario under investigation: timings for the introduction of LLINs, insecticide resistance and PBO LLINs for different malaria metrics. The
figure illustrates how insecticide resistance is incorporated into the mathematical model. Panel (A) shows parasite prevalence by microscopy in 2–10
year olds, (B) clinical incidence in the entire population (cases per 1000 people per year) and (C) the annual entomological inoculation rate (EIR). In all
three panels 4 different scenarios are run: black line shows a situation with no insecticide resistance whilst red line illustrates resistance arriving at year 6
(moderate, 50% survival measured in a bioassay); solid lines show non-PBO LLIN whilst dashed lines show PBO LLINs introduced at year 9 (vertical
dotted-dashed grey line). There is no vector control in the population up until time zero (vertical dashed grey line) at which time there is a single mass
distribution of non-PBO LLINs to 80% of the population. LLINs are redistributed every 3 years to the same proportion of the population. Mosquitoes
are entirely susceptible up until resistance arrives overnight at the start of year 6 (vertical grey dotted line). Endemicity (a variable in Figures 4 and 5) is
changed by varying the slide prevalence in 2–10 year olds at year 6 (by changing the vector to host ratio) and in this plot takes a value of 10% (as
illustrated by the horizontal green dashed line in A). The impact of insecticide resistance is predicted (in Figure 4) by averaging the clinical incidence
and EIR for the solid red lines (resistance) and solid black lines (no resistance) between the years 6 and 9 (period ). Similarly, the impact of switching
to PBO LLINs (in Figure 5) is estimated by averaging the clinical incidence and EIR for the solid red line (standard LLINs) and dashed red lines (switch
to PBO LLINs) lines between the years 9 and 12 (period ). Different scenarios with a low and high prevalence of pyrethroid resistance are shown in
Figure 1—figure supplements 1 and 2.
DOI: 10.7554/eLife.16090.003
The following figure supplements are available for figure 1:
Figure supplement 1. Scenario under investigation: example of a mosquito population with a low population prevalence of resistance.
DOI: 10.7554/eLife.16090.004
Figure supplement 2. Scenario under investigation: example of a mosquito population with a high population prevalence of resistance.
DOI: 10.7554/eLife.16090.005
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Figure 1. The figure also indicates how LLIN coverage and variables such as malaria endemicity are
incorporated in the model. Finally (4) this model is combined with bioassay and experimental hut
trial results to predict the epidemiological impact of switching from mass distribution of standard to
PBO LLIN.
Results
Defining a metric for pyrethroid resistance
The population prevalence of pyrethroid resistance is defined from the percentage of mosquitoes
surviving a pyrethroid bioassay performed according to standardised methodologies. Data from all
bioassay types (such as the WHO tube susceptibility bioassay (WHO, 2013b), WHO cone bioassay
(WHO, 2013a) or CDC tube assay [Brogdon, 2010]) are combined to produce a simple to use gen-
eralisable metric. Note that this pyrethroid resistance test does not differentiate between varying
levels of resistance within an individual mosquito as only single discriminating doses are used. It is
assumed that the ability of a mosquito to survive insecticide exposure is not associated with any
other behavioural or physiological change in the mosquito population which influences malaria trans-
mission. For example, an increased propensity for mosquitoes to feed outdoors (subsequently
referred to as behavioural resistance) would limit their exposure to LLINs though there is currently
insufficient field evidence to justify its inclusion in the model (Brie¨t and Chitnis, 2013; Gatton et al.,
2013).
Using bioassays to predict LLIN efficacy
Table 1 summarises the datasets used in the different meta-analyses. Meta-analysis M1 shows that
mosquito mortality in experimental hut trials can be predicted by the percentage of mosquitoes sur-
viving a simple pyrethroid bioassay (Figure 2A). There is a substantial association between pyre-
throid resistance in a bioassay and mortality measured in a standard LLIN experimental hut trial
(Figure 2A, Deviance Information Criteria, DIC, with resistance as an explanatory variable = 2544.0,
without = 2649.0 (lower value shows more parsimonious model), best fit parameters a1 = 0.634
(95% Credible Intervals, 95%CI, 0.012–1.29) and a2 = 3.99 [95%CI 3.171–5.12]). This indicates that
bioassay survival can be used as a quantitative test to assess how the population prevalence of pyre-
throid resistance influences LLIN efficacy. The number of studies identified in M1 is relatively small
Table 1. Summary of data collated in the three meta-analyses. The number of data points is subdivided according to the insecticides
or LLIN tested and the predominant mosquito species in each population tested. Studies which did not determine species in the
Anopheles gambiae complex are shown separately. All Published Data can be downloaded from Dryad Digital Repository whilst a list
of the studies included their geographical range are given in the Material and methods.
Meta-analysis description Details
No.
Studies
Number data points
Anopheles
gambiae s.s.
Anopheles
arabiensis
Anopheles
gambiae s.l.
Anopheles
funestus Total
M1 Bioassay and experimental hut trial
mortality
Deltamethrin 5 2 1 10 0 13
Permethrin 8 2 1 3 0 6
Other 1 0 0 1 1 2
Total 13 4 2 14 1 21
M2 Impact of PBO in pyrethroid bioassays Deltamethrin 16 15 5 29 8 57
Permethrin 20 22 7 30 9 68
Other 4 2 0 4 6 12
Total 24 39 12 63 23 137
M3 Experimental hut trials of standard and
PBO LLINS
Olyset 6 6 0 10 0 16
PermaNet 6 18 4 6 0 28
Total 12 24 4 16 0 44
DOI: 10.7554/eLife.16090.006
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(only 21 data-points) so the predictive ability of the bioassay was further validated using the A. gam-
biae s.l.PBO data (Figure 2B,C).
Added benefit of PBO
The increased mortality observed by adding the synergist PBO to a pyrethroid bioassay was
assessed for Anopheles funestus and Anopheles gambiae senu lato mosquitoes with different levels
of pyrethroid resistance (M2, Figure 2B). Data suggests that for the A. gambiae complex PBO has
the greatest benefit in mosquito populations with intermediate levels of pyrethroid resistance
(including pyrethroid resistance as an explanatory variable DIC = 2544.0, without DIC = 4748.0). In
A. funestus adding PBO appears to kill all mosquitoes irrespective of the prevalence of pyrethroid
resistance (including resistance as an explanatory variable improved model fit, with DIC = 2544.0,
without DIC = 2547.0, though the gradient of the line was so shallow as to effectively make the PBO
synergised pyrethroid mortality independent of the population prevalence of pyrethroid resistance).
The relationships identified in Figure 2A and B are used to predict the added benefit of a PBO
LLIN over a standard LLIN (Figure 2C). These predictions are consistent with the observed results
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Figure 2. The ability of the pyrethroid resistance test (the percentage mosquito survival in a bioassay) to predict the results of experimental hut trials
and the increase in mosquito mortality caused by the synergist PBO. Panel A: The relationship between mosquito mortality measured in non-PBO
WHO tube bioassay and experimental hut trials (the percentage of mosquitoes, which enter the house that die within the next 24 hr). Solid grey line
shows the best fit model for all mosquito species combined. Panel B: Differences in mosquito mortality caused by adding PBO to a pyrethroid
bioassay. Panel C: Best fit models from Panel A and Panel B were combined to predict the change in mortality seen by adding PBO to a pyrethroid
LLIN for mosquito populations with different levels of insecticide resistance. Points show the different mortalities measured from the limited number of
experimental hut trials where PBO and non-PBO nets were simultaneously tested. Overall the model appears to be a good predictor of these data,
both visually and statistically (Analysis of Variance test shows there was no significant difference between model predictions and observed data
p-value=0.25). No experimental hut trial data were available for validation of the Anopheles funestus model. Throughout all panel colour denotes
mosquito species, either Anopheles gambiae sensu lato (red) or A. funestus (blue), whilst the shape of points indicates the type of pyrethroid used:
permethrin (circle), deltamethrin (square), or other pyrethroid (diamond). In panels A and B the fill of the points indicates the type of bioassay used
(filled points = WHO cone; no fill = WHO tube; light fill = CDC bottle). Solid line shows the best fit model whilst the shaded areas indicate the 95%
credible intervals around the best fit line. In all panels the dashed lines show no difference between the x and y axes. Pre-defined search string used in
the meta-analyses are listed in Figure 2—source data 1 whilst raw data from panels A,B and C are provided in Figure 2—source data 2, Figure 2—
source data 3, and doi:10.5061/dryad.13qj2 respectively.
DOI: 10.7554/eLife.16090.007
The following source data is available for figure 2:
Source data 1. Summary of the different predefined search strings used for meta-analysis M1, M2 and M3.
DOI: 10.7554/eLife.16090.008
Source data 2. Summary of data from meta-analysis M1 presented in Figure 2A.
DOI: 10.7554/eLife.16090.009
Source data 3. Summary of data from meta-analysis M2 presented in Figure 2B.
DOI: 10.7554/eLife.16090.010
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from all published experimental hut trials directly comparing both LLIN types (M3) (see overlap of
data points with model predictions on Figure 2C) providing further independent evidence that the
population prevalence of pyrethroid resistance measured by a bioassay can be used to predict LLIN
induced mortality in a hut trial for both standard and PBO LLINs.
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Figure 3. Meta-analysis of how the different outcomes of experimental hut trials which impact LLIN efficacy change with the percentage of mosquitoes
which survive after entering the hut. (A) The probability that mosquitoes will be deterred away from a hut with an LLIN, (B) once entered the hut the
mosquito will exit without feeding, or (C) will successfully feed. Panel (D) shows how the average probability that a bloodfeeding mosquitoes will be
killed, deterred from entering, exit without feeding or successfully feed and survive during a single feeding attempt and how this changes with the
population prevalence of pyrethroid resistance (as measured as the percentage survival in a pyrethroid bioassay). The lines are drawn using the best fit
estimates from (A–C). Panel (E) shows how the longevity of the insecticide activity (estimated from washed nets) is longer in mosquito populations with
high mosquito mortality in experimental hut trials. A possible hypothesis for this change is proposed in (F) where the black line indicates how
insecticide concentration might decay over time. The time taken for a hypothetical resistant mosquito to survive the insecticide concentration (pink
arrow) may be shorter than a susceptible mosquito (purple arrow). In Panels (A), (B), (C) and (E) the points show data from experimental hut trials with
standard (green) or PBO (purple) LLINs. In (A) points which fell below the line (i.e. mosquitoes were more likely to enter huts with LLINs) were set to
zero. The black line shows the best fit model to these data whilst the shaded area denotes the 95% credible interval estimates for the best fit line.
Graphical assessment of the validity of the distributional assumptions and the posterior distributions for each parameter are shown in Figure 3—figure
supplement 1A).
DOI: 10.7554/eLife.16090.011
The following figure supplement is available for figure 3:
Figure supplement 1. Justification of normality distributed errors in the deterrence dataset (A) and posterior distributions of parameter estimates (B).
DOI: 10.7554/eLife.16090.012
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The impact of pyrethroid resistance on LLIN efficacy
Mortality in experimental huts was shown to be a useful predictor of LLIN induced deterrence, exit-
ing and the rate of pyrethroid decay (Figure 3A–C). Figure 3A indicates that the number of mosqui-
toes deterred from entering the experimental hut substantially decreases in areas of higher
pyrethroid resistance (where LLIN induced mortality inside the hut is low) though the variability
around the best fit line is high suggesting the precise shape of the relationship is uncertain. As the
population prevalence of pyrethroid resistance increases (and mortality inside the hut decreases) an
clinical incidence 
1000/year
EIR/year
Figure 4. The predicted impact of pyrethroid resistance on the clinical incidence of malaria (Panels A and B) and the force of infection (Panel C). Panel
(A) shows how the number of clinical cases in the population increases with the population prevalence of pyrethroid resistance (as assessed by the
percentage survival in a pyrethroid bioassay) for a single setting (with 10% slide prevalence). Black lines show the full resistance model whilst the brown
lines give predictions for mosquito populations where the rate of change in insecticide activity over time is the same for all mosquitoes (i.e. resistance
has no impact on LLIN longevity). Solid lines show the average for the population, shaded grey area indicates the 95% credible intervals around this
best fit line, dashed lines denote those using bednets whilst dotted-dashed lines show those who do not. Panel (B) shows the 3D relationship between
prevalence of resistance (x-axis), endemicity (y-axis) and the absolute increase in the number of clinical cases (contours, see colour legend) per 1000
people (all ages). Panel (C) presents the same model as (B) though showing the absolute increase in the entomological inoculation rate (EIR, the
average number of infectious bits per person per year). In this figure it is assumed that the mosquito species is Anopheles gambiae sensu stricto and
that there is 80% LLIN coverage. Figure 4—figure supplement 1 shows the same figure with 50% LLIN coverage. Further secondary figures indicate
how the impact of resistance changes with mosquito species, be it Anopheles arabiensis (Figure 4—figure supplement 2) or Anopheles funestus
(Figure 4—figure supplement 3). Panel (A) shows the importance of the rate of change in insecticide activity over time. Figure 4—figure supplement
4 shows how Panels B and C would change if the rate of decay in insecticide activity was the same for resistant and susceptible mosquitoes. The
uncertainty in the three LLIN efficacy parameters used to generate the confidence interval estimates in Panel (A) are shown in (Figure 4—figure
supplement 5) for different levels of pyrethroid resistance.
DOI: 10.7554/eLife.16090.013
The following figure supplements are available for figure 4:
Figure supplement 1. The predicted impact of pyrethroid resistance on the clinical incidence of malaria (Panels A and B) and the force of infection
(Panel C) in an area with A. gambiae s.s. mosquitoes and 50% LLIN coverage.
DOI: 10.7554/eLife.16090.014
Figure supplement 2. The predicted impact of pyrethroid resistance on the clinical incidence of malaria (Panels A and B) and the force ofinfection
(Panel C) in an area with A. arabiensis mosquitoes and 80% LLIN coverage.
DOI: 10.7554/eLife.16090.015
Figure supplement 3. The predicted impact of pyrethroid resistance on the clinical incidence of malaria (Panels A and B) and the force of infection
(Panel C) in an area with A. funestus mosquitoes and 80% coverage.
DOI: 10.7554/eLife.16090.016
Figure supplement 4. The predicted impact of pyrethroid resistance on (A) the clinical incidence of malaria and (B) the force of infection when
pyrethroid resistance does not influence the rate of decay in LLIN insecticide activity over time (i.e. resistance has no impact on LLIN longevity).
DOI: 10.7554/eLife.16090.017
Figure supplement 5. Estimates in the uncertainty of the three LLIN efficacy parameters for different levels of pyrethroid resistance.
DOI: 10.7554/eLife.16090.018
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increasing proportion of mosquitoes entering the house exit without blood-feeding (Figure 3B).
Only when there is a very high population prevalence of pyrethroid resistance does the probability
that a mosquito will successfully feed start to increase (Figure 3C). Changing behaviour of a host
seeking mosquito with different levels of pyrethroid resistance is shown in Figure 3D.
The overall efficacy of an LLIN depends on its initial efficacy and the rate at which this changes
over the life-time of the net. Since there are currently no published durability studies in areas of high
pyrethroid resistance or with PBO LLINs we estimate the loss of insecticidal activity from experimen-
tal hut trials using washed nets. Results indicate that washing decreases efficacy fastest in areas of
higher pyrethroid resistance. Figure 3E shows estimates of the decay in pyrethroid activity assuming
that the loss of efficacy due to washing is proportional to the change in activity seen over time (i.e. if
the rate of decay over subsequent washes is twice as fast in a resistant mosquito population than
the decay of pyrethroid activity over time will also be twice as fast). Mosquitoes with high pyrethroid
resistance appear to overcome the insecticide activity of the LLIN faster than susceptible mosqui-
toes. A hypothesis for the cause of this relationship is outlined in Figure 3F.
The public health impact of pyrethroid resistance
The transmission dynamics model predicts that the higher the population prevalence of pyrethroid
resistance the greater impact it will have on both the number of clinical cases (Figure 4A and B) and
the force of infection (as measured by the EIR, Figure 4C). This is due to the lower initial killing effi-
cacy of the LLIN but also because of the higher rate of decay of insecticidal activity (it gets less effec-
tive more quickly). The absolute increase in EIR caused by resistance increases in areas of high
endemicity (Figure 4C), though the model predicts that the number of clinical cases caused will
peak at intermediate parasite prevalence because high levels of clinical immunity will mask increased
infection rates in hyper-endemic areas. Understandably the impact of resistance will depend on the
current LLIN coverage, with the total public health impact of resistance being greatest in areas
where bednets were having the highest impact (i.e. areas of lower, 50%, coverage, see Figure 4—
figure supplement 1). Equally the impact of resistance will be higher in areas with mosquito species
which are more amenable to control through the use of LLINs (i.e. greater in Anopheles gambiae
sensu stricto than Anopheles arabiensis, Figure 4—figure supplements 2 and 3). The transmission
dynamics model predicts that the public health impact of pyrethroid resistance will be high. For
example with as little as 30% resistance (70% mortality in discriminating dose assay) in a population
with 10% slide prevalence (in 2–10 year olds) the model predicts that pyrethroid resistance would
cause an additional 245 (95%CI 142–340) cases per 1000 people per year (Figure 4A, averaged over
the 3 year life-expectancy of the net). Similar increases in the number of cases are seen in those with
or without LLINs (Figure 4A).
The public health benefit of switching to PBO LLINs
The impact of the addition of the synergist, PBO, on pyrethroid induced mortality appears to
depend on mosquito species and the population prevalence of pyrethroid resistance. In mosquito
populations with moderate to high resistance results indicate PBO is an effective synergist of pyreth-
roids (Figure 5A). For example in an area with 10% endemicity and 80% resistance (20% mortality in
discriminating dose assay) the model predicts that switching to PBO LLINs would avert an additional
501 (95%CI 319–621) cases per 1000 people per year (Figure 5A) compared to the same level of
standard LLIN coverage. The absolute number of cases averted by switching to PBO LLINs is pre-
dicted to be greater in areas with intermediate endemicity as human immunity is likely to partially
buffer the added benefit of PBO LLINs in areas of highest malaria prevalence (Figure 5B). However,
due to the non-linear relationship between incidence of clinical infection and endemicity, the great-
est percentage reduction in clinical cases and EIR is seen in areas of low endemicity (Figure 5CF).
The exact change in clinical cases will vary between settings. For example switching from 80% cover-
age with standard LLINs to 80% coverage with PBO LLINs in an area with 30% endemicity and a
mosquito population with 60% pyrethroid resistance is predicted to reduce the number of clinical
cases by ~60% whereas the same switch in the type of nets used in an area with 30% endemicity and
20% pyrethroid resistance would only reduce the number of clinical cases by ~20% (Figure 5C).
Greater percentage reductions are likely to be seen in EIR than the number of clinical cases due to
human immunity (Figure 5E).
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Figure 5. Predicting the added benefit of switching from standard LLINs to combination PBO nets. Panels (A–C) show clinical incidence (per 1000
people per year, all ages) whilst Panels (D–F) gives the entomological inoculation rate (EIR, infectious bites received per person per year). (A) and (D)
show how malaria incidence and the force of infection increase with the population prevalence of pyrethroid resistance (as assessed by the percentage
survival in a pyrethroid bioassay) in a single setting (with 10% slide prevalence) for standard LLINs (green line) and PBO LLINs (purple line). Shaded
region denotes the 95% credible intervals around the best fit lines. Panels (B) and (E) show the 3D relationship between the prevalence of resistance (x-
axis), endemicity (y-axis) and the absolute number of cases (and EIR) averted by switching to PBO LLINs. (C) and (F) give 3D relationship for the
percentage reduction in cases and EIR (respectively) caused by switching from standard to PBO LLINs. The non-linear relationship between endemicity,
clinical incidence and EIR means that the greatest percentage reduction is seen at low endemicities despite the greatest absolute reduction being in
higher transmission settings. In all Panels it is assumed that the mosquito species is Anopheles gambiae sensu stricto and that there is 80% LLIN
coverage. Figure 5—figure supplement 1 shows the same figure with 50% LLIN coverage. Further secondary figures indicate how the impact of
resistance changes with mosquito species, be it Anopheles arabiensis (Figure 5—figure supplement 2) or Anopheles funestus (Figure 5—figure
supplement 3).
DOI: 10.7554/eLife.16090.019
The following figure supplements are available for figure 5:
Figure supplement 1. Predicting the added benefit of switching from standard LLINs to combination PBO nets in an area with A. gambiae s.s.
mosquitoes and 50% LLIN coverage.
DOI: 10.7554/eLife.16090.020
Figure supplement 2. Predicting the added benefit of switching from standard LLINs to combination PBO nets in an area with A. arabiensis
mosquitoes and 80% LLIN coverage.
DOI: 10.7554/eLife.16090.021
Figure supplement 3. Predicting the added benefit of switching from standard LLINs to combination PBO nets in an area with A. funestus mosquitoes
and 80% LLIN coverage.
DOI: 10.7554/eLife.16090.022
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Discussion
Pyrethroid resistance is widespread across Africa though its public health impact is unknown. Here
we show that the simple bioassay can be used to predict how pyrethroid resistance is changing the
efficacy of different types of LLIN and how this would be expected to influence malaria morbidity.
The bioassay is a crude tool for measuring pyrethroid resistance, though its simplicity makes it
feasible to use on a programmatic level. Figure 2A and C indicate that on average bioassay mortal-
ity is able to predict the results of standard and PBO LLIN experimental hut trials for A. gambiae s.l.
mosquitoes. There is a high level of measurement error in the bioassay (as seen by the wide variabil-
ity in points in Figure 2A and B) so care should be taken when interpreting the results of single
assays as differences in mosquito mortality may have been caused by chance. Multiple bioassays
could be conducted on the same mosquito population and the results averaged to increase confi-
dence. However the exact cause of the measurement error remains unknown so increased repetition
many not necessarily generate substantially more accurate results as possible causes of variability,
such as mosquito husbandry techniques or environmental conditions (Kleinschmidt et al., 2015),
may be repeated. Further work is therefore needed to determine whether assay repetition substan-
tially improves overall accuracy or whether further standardisation or more complex assays are
required. The majority of data are for A. gambiae s.l. so the analysis needs to be repeated for other
species once data becomes available. More advanced methods of measuring insecticide resistance
(such as the intensity bioassay [Bagi et al., 2015] or the use of genetic markers [Weetman and Don-
nelly, 2015]) are likely to be a more precise way of predicting resistance. However, since there are
insufficient data to repeat these analyses with these other assays their predictive ability remains
untested. Similarly, this analysis has grouped WHO tube, WHO cone and CDC bottle assays
together when the use of a single assay type might be more predictive.
The meta-analysis of experimental hut trials in areas with different levels of resistance has impor-
tant implications for our understanding of how pyrethroid resistance influences LLIN efficacy. This
analysis suggests that the probability that a mosquito will feed on someone beneath an LLIN only
increases substantially at high levels of pyrethroid resistance (Figure 3C). People under bednets
exposed to mosquito populations with intermediate levels of resistance still have a high degree of
personal protection whilst in bed as those mosquitoes, which do not die are likely to exit the hut
without feeding. It is only when mosquito populations are highly resistant (>60% survival) that an
increasing proportion of mosquitoes appear to successfully feed through the LLIN (Figure 3D). This
may explain why a previous meta-analysis on the impact of pyrethroid resistance on LLIN efficacy in
experimental hut trials failed to find a substantial effect (Strode et al., 2014) as resistance was cate-
gorised into broad groups (partially based on highly variable bioassay data) unlike here where resis-
tance is treated as a continuous variable (as measured using experimental hut trial mortality data
which are less variable than bioassay data). This earlier study also only analysed papers published or
presented prior to May 2013 and so it did not include the recent experimental hut trials which had
the lowest mosquito mortality (Toe´, 2015; Pennetier et al., 2013).
The meta-analysis revealed that the number of mosquitoes deterred from entering a hut with an
LLIN, decreases with increasing pyrethroid resistance. LLIN efficacy is therefore reduced as mosqui-
tos enter huts where they have both a higher chance of feeding and a lower chance of being killed.
These parallel changes in behaviour increase the resilience of mosquito populations to LLINs as in a
susceptible mosquito population, high deterrence will reduce LLIN efficacy by preventing mosqui-
toes entering houses where they have a high chance of being killed (relative to susceptible popula-
tions). Importantly the loss of deterrence suggests that those sleeping in a house with an LLIN
though not sleeping under the net themselves (a phenomenon particularly common in older children
[Nankabirwa et al., 2014]) will lose an additional degree of protection (on top of the community
impact of mosquito killing).
The overall effectiveness of LLINs depends on the duration of insecticidal activity. Evidence sug-
gests that multiply washed LLINs lose their ability to kill mosquitoes more in areas of high pyrethroid
resistance. Washing is seen as an effective method of aging LLINs (WHO, 2013a). Repeatedly wash-
ing a net (and presumably reducing the concentration of the insecticide) appears to have little
impact on its ability to kill a susceptible mosquito whilst significantly reducing the lethality of the
LLIN against more resistant mosquitoes (Figure 2E). The difference in mortality is likely to be caused
by mosquitoes with a higher population prevalence of resistance being able to tolerate a higher
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concentration of insecticide (WHO, 2013a). If so, then the higher longevity of LLINs against suscepti-
ble mosquitoes observed in the washed net data may be explained by the longer time it takes for
the insecticide concentration on the LLIN to drop below this critical level (Figure 2F). This analysis
assumes that the decay in pyrethroid activity over time is proportional to its decay following washing
and this needs to be confirmed by durability studies in areas of high pyrethroid resistance. Neverthe-
less the results seem to be confirmed by two recent studies which evaluated mosquito mortality in
older (standard) LLINs (Toe´ et al., 2014; Wanjala et al., 2015). Durability studies should be priori-
tised as the model predicts that, even at low levels of pyrethroid resistance, the loss of insecticide
activity over the three year bednet life-expectancy, has a bigger epidemiological impact on malaria,
than the initial efficacy of new LLINs. If confirmed then more regular net distribution could be consid-
ered as a temporary, albeit expensive, method to mitigate the public health impact of high pyre-
throid resistance.
Transmission dynamics mathematical models are a useful tool for disentangling the different
impacts of LLINs. Though a person under an LLIN requires high pyrethroid resistance before LLINs
start to fail (Figure 3C), the models predict that at a population level even low pyrethroid resistance
can increase the number of malaria cases over the life-time of the net (Figure 4A). Hut trials measure
feeding when the volunteer is underneath a bednet whilst in reality (and in the mathematical model)
a percentage of mosquito bites are taken when people are not in bed. The loss of LLIN induced
mosquito mortality is likely to decrease the community impact of LLINs, increasing average mosquito
age and the likelihood that people are infected whilst unprotected by a bednet. This is primarily due
to the shorter duration of insecticide potency of LLINs in mosquito populations with a higher preva-
lence of resistance (Wanjala et al., 2015). Without this change in the duration of pyrethroid activity,
the epidemiological impact of pyrethroid resistance will only become evident once it reaches a high
level (Figure 4A). The change in the community impact of LLINs can be seen in the increase in the
number of cases in people who do not use nets. This change is substantial, reinforcing the need to
consider community effects in any policy decision.
Detecting an epidemiological impact of a low population prevalence of resistance may be chal-
lenging for local health systems (for example, see < 20% resistance prevalence Figure 1—figure
supplement 1, Figure 4) especially in an area where LLIN coverage, local climatic conditions and
the use of other malaria control interventions are changing over time. These simulations also assume
that resistance arrives overnight, when in reality it will spread through a mosquito population more
gradually and therefore may be harder to detect. Mosquitoes exposed to LLINs may have reduced
fitness (Viana et al., 2016). Currently the model assumes that mosquitoes which survive 24 hr after
LLIN exposure are indistinguishable from unexposed mosquitoes. If this is not the case then hut trials
data alone will be insufficient to predict the public health impact of pyrethroid resistance as current
models will over-estimate its impact. Similarly, if the mosquito population exhibits additional behav-
ioural mechanisms to avoid LLINs, such as earlier biting times, in tandem to the increased tolerance
of pyrethroid insecticide then the predictions presented here will likely underestimate the public
health impact as this behaviour change has not been incorporated.
Currently a mosquito population is defined as being pyrethroid resistant if there is < 90% bioas-
say mortality (WHO, 2013b; Mnzava et al., 2015). Though useful, this entomological measure
should not be considered as a measure of the effectiveness of pyrethroid LLINs. The personal pro-
tection provided by sleeping under an LLIN is likely to be substantial even at very high levels of resis-
tance (Strode et al., 2014; Randriamaherijaona et al., 2015). Any reduction in mosquito mortality
will likely reduce the community impact of LLINs though it may be hard to detect, especially in areas
with new LLINs (the public health impact of resistance is likely to be greater in older nets,
Figure 3E). As with all transmission dynamic mathematical models, these predictions need to be vali-
dated in particular locations with well-designed studies combining epidemiological and entomologi-
cal data. We are currently unaware of any published data with sufficient information to test the
model against though a thorough validation exercise should be carried out as soon as such studies
become available. Currently the meta-analyses and transmission dynamics models concentrated on
malaria in Africa and give predictions for the three primary mosquito vector species found there.
Each meta-analyses has data from multiple countries but these sites are not geographically represen-
tative of the whole of malaria endemic Africa. Though the principles outlined here may apply to
other mosquito species in different care settings should be taken when extrapolating the results
beyond the areas where the data were collated.
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The bioassay data indicate that the ability of PBO to synergise pyrethroid induced mortality
depends on the mosquito species. In A. funestus PBO always appears to restore near 100% mortality
whilst for mosquitoes from the A. gambiae complex the greatest additional benefit of PBO being
seen at intermediate levels of pyrethroid resistance (Figure 2B). The exact causes of this are
unknown but is likely related to the predominant resistance mechanisms in each species. PBO’s pri-
mary synergistic effect of pyrethroids is thought to be due to the inhibition of the cytochrome P450
enzymes which catalyse the detoxification of the insecticides (Farnahm, 1998). Elevated P450 levels
are the primary resistance mechanism in A. funestus whereas in A. gambiae s.l. both increased
detoxification and alterations in the target site contribute to pyrethroid resistance with the latter
mechanism being largely unaffected by PBO (Mulamba et al., 2014; Riveron et al., 2013).
For A. gambiae s.l. populations this result was verified by experimental hut trial data which
directly compare standard and PBO LLINs (Figure 2C). Both bioassay and hut trial data suggest
a minimal additional benefit of PBO in areas with very high levels of pyrethroid resistance. Unfortu-
nately, there are currently no published studies where PBO LLINs have been tested in experimental
hut trials in areas with A. funestus so these bioassay results should be treated with caution until they
can be further verified. Additional data would also allow the differences between species in the
A. gambiae complex to be assessed. A previous analysis comparing PermaNet 2.0 and 3.0 was
unable to test whether the increase in efficacy of the PBO LLIN was solely due to the addition of
PBO as this net has a higher concentration of insecticide (Brie¨t et al., 2013). The results presented
here show a consistent pattern between PermaNet 2.0 and 3.0 and Olyset and Olyset Plus. As both
Olyset nets have the same concentration of insecticide, this suggests that PBO is causing the
enhancement of efficacy.
The WHO recommends that countries routinely conduct non-PBO pyrethroid bioassays as part of
their insecticide resistance management plan (WHO, 2012). In areas with A. gambiae s.l. the evi-
dence presented here suggests that the results of bioassays with and without PBO can be used to
predict the additional public health benefit of PBO LLINs. If there is a greater mortality in the PBO
bioassay and the relative mortalities broadly agree with the red curve in Figure 2B, then Figure 5B
can be used to predict the approximate number of cases that will be saved by switching from stan-
dard to PBO LLINs (for a given level of endemicity and LLIN coverage). Areas with 40–90% survival
(10–60% mortality) in a non-PBO standard bioassay (of any type) should consider conducting PBO
synergism bioassays to determine the suitability of PBO LLINs. We would suggest that either the
WHO cone, WHO tube or CDC bottle assay (conducted in triplicate and averaged to improve preci-
sion) should be sufficient evidence to justify the need to switch to PBO LLINs.
The decision to recommend PBO nets over standard LLINs requires information on the relative
cost effectiveness and affordability of PBO nets. If both net types cost the same and resistance has
been detected then this work indicates that PBO LLINs should always be deployed as evidence sug-
gests that they are always more effective. However, if PBO nets are more expensive, then cost effec-
tiveness analysis will be required. The results of such analysis are likely to be context specific
(depending on price, resistance level, endemicity and coverage) and interpreting them will require
information on decision makers’ willingness and ability to pay for additional effectiveness. In many
situations, malaria control budgets are likely to be fixed and therefore switching to more expensive
PBO LLINs may cause a reduction in overall bednet coverage. The impact of reduced coverage must
therefore be off set against the benefits of introducing PBO nets, taking into consideration any addi-
tional factors such as changed programmatic costs, and equity issues.
Rapid deployment of new vector control products saves lives and gives incentives for industry to
invest in new methods of vector control. New methods are likely to have a higher unit price than
existing tools so it is important to be able to determine where and when they should be deployed in
an efficient and transparent manner. Frameworks such as those presented here offer a relatively
straightforward method of comparing two different products to determine whether the increased
effectiveness justifies the higher unit price.
Much of the debate over the impact of pyrethroid resistance on LLIN effectiveness has focused
on the loss of personal protection provided by new nets and does not fully take into account their
community impact. A large body of evidence has shown how widespread use of LLINs can cause
considerable community protection, both to those who use bednets and non-users (Killeen, 2007
and references therein). Therefore the community impact should be considered in any study investi-
gating the consequences of pyrethroid resistance (Brie¨t et al., 2013; Killeen, 2014), as any
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reduction in mosquito killing is likely to increase malaria cases even in areas with mildly resistant
mosquito populations where LLINs are still providing good personal protection. The evidence pre-
sented here suggests that high levels of pyrethroid resistance are likely to have a bigger public
health impact than previously thought and therefore could represent a major threat to malaria con-
trol in Africa.
Materials and methods
Description of data
To generate results which are broadly applicable to all mathematical models were fit to data com-
piled by systematic meta-analyses of the published literature. Where possible meta-analyses were
extended to the grey literature by including unpublished information. These include unpublished
bioassay data from Liverpool School of Tropical Medicine, submissions to the World Health Organi-
sation Pesticide Evaluation Scheme (WHOPES) and results from unpublished experimental hut trials
(collated by contacting LLIN manufacturers Vestergaard-Frandsen and Sumitomo Chemicals Ltd).
The meta-analyses followed the Preferred Reporting Items for Systematic Reviews and Meta-Analy-
ses guidelines (Moher et al., 2009) for study search, selection and inclusion criteria though the study
was not registered. The predefined inclusion criteria of each of the meta-analyses are presented in
Table 2 whilst the pre-defined search strings and the databases searched are outlined in full in Fig-
ure 2—source data 1. Extraction was done by N.L. into piloted forms. Study corresponding authors
were contacted for raw data when this information was unavailable (all contacted investigators
responded with the requisite information).
Impact of pyrethroid resistance on LLIN mortality
To determine whether simple pyrethroid bioassays can be used to infer the outcome of experimental
LLIN hut trials a meta-analysis (summarised as Meta-analysis 1, M1) was conducted to identify studies
Table 2. Inclusion and exclusion criteria used when conducting literature searches of published and grey literature. Pre-defined search
string used are listed in Figure 2—source data 1.
Inclusion criteria Exclusion criteria
General criteria across all meta-analyses
– Mosquito belong to the A. gambiae complex or A. funestus group
– Study conducted in Africa
– Bioassay must be of the standard dose for the particular pyrethroid
(WHO, 2013a, 2013b; Brogdon, 2010)
– Net must be a pyrethroid LLIN
– Studies which report percentage mortality but not the numbers tested
/ caught†
– Experimental hut trials which do not have adequate design to reduce
bias (i.e. treatments arms were not rotated between huts; sleeper bias
unaccounted for by preliminary testing; randomisation or rotation; huts
were not cleaned between treatments)
– Experimental huts of the Ifakara design‡
M1 – Bioassay and experimental hut trial mortality
– Mosquito mortality measured in both an experimental hut study and
separate bioassay (e.g. WHO tube assay, WHO cone assay, CDC bottle
assay)
– Cone assays where the net had been washed
M2 – Impact of PBO in pyrethroid bioassays
– adult mosquito stage exposure to PBO
M3 – Experimental hut trials of standard and PBO LLINS
– Study compares a combination LLIN (PermaNet 3.0 or Olyset Plus) with a
conventional LLIN (PermaNet 2.0 or Olyset Net)*
– LLINs should be holed (Six 4  4 cm holes)
– Studies without both standard and PBO LLINs as non-parallel studies
as studies from different sites may bias the difference between LLINs
– Trials without untreated control nets
– Studies which did not include feeding success
* currently there are only two commercially available LLINs with PBO, PermaNet 3.0 (Vestergaard-Frandsen) and Olyset Plus (Sumitomo Chemicals Ltd).
To limit the difference between LLIN types only nets made by the same manufacturer are directly compared.
† to increase the size of the bioassay dataset the authors of papers which failed to give sample sizes were contacted directly.
‡ The probability that a mosquito will die in an experimental hut will depend on the hut design. To minimise the difference between studies, the most
common design of hut is used, excluding the small number of studies which use the new Ifakara design (eg. Okumu et al., 2013).
DOI: 10.7554/eLife.16090.023
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where both were carried out concurrently. To test whether this relationship changed with the popu-
lation prevalence of insecticide resistance simple functional forms were fit to the raw data using a
mixed-effect logistic regression (summarised as Relationship 1, R1). There has been an attempt to
standardise bioassay and experimental hut trial procedures to enable data from different studies to
be directly compared. These include using standard concentrations of insecticide, mosquito expo-
sure time and mosquito husbandry in bioassays, hut design, trap type and the use of human baits in
experimental hut trials. Nevertheless, some procedural discrepancies remain between studies, for
example, in bioassays the age and sex of mosquitoes and how they were collected (e.g. F1 progeny
of wild caught mosquitoes or wild caught larvae reared in insectary and tested as adults). These co-
variates and others (for example information on genetic markers associated with insecticide resis-
tance), could be included within the analysis, though their addition would increase data needs of
future studies and complicate the use of study results. Instead a mixed-effects binomial regression is
adopted which allows mosquito mortality to vary at random between studies. This statistical method
enables a wider selection of studies to be included within the analysis, produces more generalizable
results and reduces problems caused by data autocorrelation. Mosquito mortality in an experimental
hut trial is defined as the proportion of mosquitoes, which enter the hut which die, either within the
hut or within the next 24 hr.
Meta-analysis 1 (M1) identified only 7 studies where concurrent bioassays and experimental hut
trials were carried out (Table 3). Given the paucity of data results from all types of bioassay and mos-
quito species were combined and a simple, functional form was used to describe the relationship
(the fixed-effect). Let x denote the proportion of mosquitoes dying in a standard (non-PBO) pyre-
throid bioassay then the population prevalence of pyrethroid resistance (expressed as a percentage,
denoted I) is described by the following equation,
I ¼ 100 1  xð Þ: [1]
Extending the notation of Griffin et al. (2010) the proportion of mosquitoes, which died in a hut
trial is denoted lp, where subscript p indicates the net type under investigation, be it a no-net control
hut (p¼ 0), a standard non-PBO LLIN (p¼ 1), or a PBO LLIN (p¼ 2). For a standard LLIN it is assumed
to be explained by the equation,
logit l1ð Þ ¼ a1þa2 x  tð Þ; [2]
Table 3. List of studies identified in meta-analysis M1 - Predicting LLIN effectiveness from bioassay
mortality. Pre-defined search string used in the meta-analyses are listed in Figure 2—source data 1
whilst raw data from are provided in Figure 2—source data 2.
Study Reference Test Country
1 Ngufor et al. (2014a) WHO tube Coˆte d’Ivoire
2 Ngufor et al. (2014b) WHO tube Benin
3 Kitau et al. (2014) WHO tube Tanzania
4 Asale et al. (2014) WHO tube Ethiopia
5 Ngufor et al. (2014c) WHO tube Burkina Faso
6 Agossa et al. (2014) WHO tube Benin
7 Malima et al. (2013) WHO tube Tanzania
8 Adeogun et al. (2012b) WHO tube Nigeria
9 Koudou et al. (2011) WHO tube Coˆte d’Ivoire
10 Corbel et al. (2010) WHO tube Benin, Burkina Faso, Cameroon
11 Tungu et al. (2010) WHO tube Tanzania
12 Malima et al. (2008) WHO tube Tanzania
13 Ke´toh (2016) WHO tube Togo
14 Toe´ (2015) WHO tube Burkina Faso
DOI: 10.7554/eLife.16090.024
Churcher et al. eLife 2016;5:e16090. DOI: 10.7554/eLife.16090 14 of 26
Research article Epidemiology and Global Health
where parameters a1 and a2 define the shape of the relationship and t is a constant used to centre
data to aid the fitting process. More sophisticated functional forms could be used for
R1 (Equation [2]) though they were not currently warranted given the limited dataset. Let Np indicate
the number of mosquitoes entering a hut in an experimental hut trial. If the number of these mosqui-
toes which enter the hut and subsequently die (L1) follows a binomial distribution then parameters
a1 and a2 can be estimated for a non-PBO net by fitting the following equation to M1,
L1 ~B l1;N1ð Þþ a: [3]
The random-effects component is included by allowing mortality to vary at random between sites by
adding the error term a which has a mean of zero and a constant variance.
Table 4. List of studies identified in meta-analysis M2 - Estimating the impact of PBO in pyrethroid
bioassays. Bioassays run using laboratory strains are denoted. * Pre-defined search string used in the
meta-analyses are listed in Figure 2—source data 1 whilst raw data from are provided in Figure 2—
source data 3.
Study Reference Test Country
1 Matowo et al. (2015) CDC tube Tanzania
2 Farnahm (1998) WHO tube Uganda & Kenya
3 Choi et al. (2014) WHO tube Zambia & Zimbabwe
4 Edi et al. (2014) WHO tube Coˆte d’Ivoire
5 Jones et al. (2013) WHO tube Zanzibar
6 Chouaı¨bou et al. (2014) WHO tube Coˆte d’Ivoire
7 Koffi et al. (2013) WHO tube Coˆte d’Ivoire
8 Witzig et al. (2013) WHO tube Chad
9 Darriet and Chandre (2013) WHO tube *
10 Mawejje et al. (2013) WHO tube Uganda
11 Adeogun et al. (2012b) WHO tube Nigeria
12 Nardini et al. (2012) WHO tube Nigeria
13 Darriet and Chandre (2011) WHO tube South Africa & Sudan
14 Kloke et al. (2011) WHO cone *
15 Awolola et al. (2009) WHO tube Mozambique
16 Brooke et al. (2001) WHO tube Nigeria
17 N’Guessan et al. (2010) WHO tube Mozambique
18 Ranson (2015) Personal Communication WHO tube Burkina Faso/Benin
19 Ranson (2015) Personal Communication WHO tube Chad colony
20 Morgan (2015) Personal Communication WHO tube Coˆte d’Ivoire
21 Ranson (2015) Personal Communication WHO tube Benin
22 Koudou & Malone (2015) Personal Communication WHO cone Coˆte d’Ivoire
23 PMI (2014). Personal Communication CDC tube Mali
24 Toe´ (2015) WHO tube Burkina Faso
25 Abı´lio et al. (2015) WHO cone Mozambique
26 Riveron et al. (2015) WHO cone Malawi
27 Awolola et al. (2014) WHO cone Nigeria
28 Yewhalaw et al. (2012) WHO cone Ethiopia
DOI: 10.7554/eLife.16090.025
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Estimating the impact of PBO on pyrethroid induced mortality
The number of experimental hut trials investigating the difference between standard and PBO nets
is limited. Instead a meta-analysis of all bioassay data investigating the impact of PBO on pyrethroid
induced mosquito mortality is undertaken incorporating all published and unpublished literature
(M2, Table 4). Bioassay mortality can be influenced by a multitude of factors including assay type,
temperature and relative humidity (Kleinschmidt et al., 2015). To account for this difference
between studies, the relationship between the benefit of adding PBO and the population prevalence
of pyrethroid resistance was estimated using a mixed-effect logistic regression (R2). Preliminary anal-
ysis suggests that the shape of the relationship is relatively complex and cannot simply be described
by the use of a standard linear function typically used in regression. Since the added benefit of PBO
in a given population will ultimately be determined by the shape of this relationship a variety of dif-
ferent functional forms are tested statistically. It was initially intended to include the type of assay
used (e.g. WHO tube assay, WHO cone assay or CDC bottle assay) as an additional fixed effect,
though the paucity of data (especially comparing bioassay mortality to experimental hut trial mortal-
ity) meant that data from all assays were combined and this covariate was excluded. As the same
type of assay are used for both non-PBO and PBO tests this should not bias the results and will gen-
erate recommendations that are generalizable across all three assay types. The proportion of mos-
quitoes killed by pyrethroid insecticide in a bioassay with the addition of PBO is denoted f and is
given by the equation:
logit fð Þ ¼ b1þ
b2 x  tð Þ
1þb3 x  tð Þ
[4]
where x is the proportion of mosquitoes dying in a non-PBO bioassay, parameters, b1; b2 and b3
define the shape of the relationship and t is a constant supporting the fitting process (this relation-
ship is referred to as R2). Let Ai be the number of mosquitoes used in a bioassay and Di the number
which died, with subscript i denotes whether or not PBO was added to the bioassay (i = 1 pyrethroid
alone, i = 2 pyrethroid plus PBO). If it is assumed that the number of mosquitoes that die in the bio-
assay follows a binomial distribution then parameters, b1; b2 and b3 can be estimated by fitting the
following equations to the dataset from (M1),
D1 ~B x;A1ð Þþ b; [5]
D2 ~B f ;A2ð Þþ b: [6]
Parameter b represents a normally distributed random error with a mean of zero and a constant var-
iance and is estimated from the fitting procedure.
Table 5. List of studies identified in meta-analysis M3 - Estimating the impact of PBO in experimental
hut trials. Pre-defined search string used in the meta-analyses are listed in Figure 2—source data 1
whilst raw data from published studies are provided at doi:10.5061/dryad.13qj2.
Study Reference Country
1 Pennetier et al. (2013) Benin, Cameroon
2 Adeogun et al. (2012a)) Nigeria
3 Corbel et al. (2010) Benin, Burkina Faso, Cameroon
4 Tungu et al. (2010) Tanzania
5 N’Guessan et al. (2010) Benin
6 Ke´toh et al., Unpublished Togo
7 Tungu et al., Personal Communication Tanzania
8 Toe´ et al., Personal Communication Burkina Faso
DOI: 10.7554/eLife.16090.026
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Predicting the added benefit of PBO LLINs in experimental hut trials
Relationships R1 and R2 can be used to predict the effectiveness of PBO LLINs in experimental hut
trials. When bioassay data are unavailable the current population prevalence of insecticide resistance
can be predicted from mosquito mortality measured in a standard LLIN experimental hut trial by
rearranging Equation [2],
x^¼
exp l1ð Þ
1  exp l1ð Þ
 
 a1
 
=a2þ t; [7]
where the section in round brackets is the inverse logit function. This equation together with Equa-
tions [2] and [4] can be then used to predict the relationship between hut trial mortality in standard
and PBO LLINs for a range of areas with different levels of pyrethroid resistance using the following
steps (a) to (c) below.
a. For a range of values of l1 (proportion of mosquitoes which died in a standard LLIN hut trial)
generate the predicted population prevalence of mosquito mortality in a bioassay expected in
the population x^ using Equation [7].
b. Use x^ to predict pyrethroid induced mortality in a bioassay with PBO f^ given the current popu-
lation prevalence of pyrethroid resistance (i.e. substitute x^ for x in Equation [4]).
c. Convert the expected mortality in a bioassay f^ into the expected mortality in a PBO LLIN hut
trial (i.e. substitute f^ for x^ in Equation [2]).
To test the predictive ability of R1 and R2 a third meta-analysis was carried out for all experimen-
tal hut trials which directly compare standard and PBO pyrethroid LLINs (M3, Table 5). The accuracy
of these predictions can then be examined by comparing them visually (Figure 2C) or statistically
using an Anaylsis of Variance.
Quantifying the impact of standard and PBO LLINs in the presence of
insecticide resistance
The impact of insecticide resistance on mosquito interactions with LLINs is systematically investi-
gated by analysing the experimental hut trials identified in M3. Restricting the analysis to the two
most commonly used standard LLINs minimises the inter-study variability and allows the different
behaviours of mosquitoes exposed to standard and PBO LLINs to be directly assessed. Following a
widely used transmission dynamics model of malaria (Griffin et al., 2010; Walker et al., 2015) it is
assumed that an LLIN can alter a host-seeking mosquito behaviour in one of three ways: firstly it can
deter a mosquito from entering a hut (an exito-repellency effect); secondly the mosquito can exit
the hut without taking a bloodmeal; and thirdly it could kill a mosquito (with the mosquito either
being fed or unfed). A mosquito that isn’t deterred, exited or killed will successfully blood-feed and
survive. The public health benefit of LLINs depends not only on their initial effectiveness but also on
how the properties of the net changes over its life-time. The ability of a net to kill a mosquito will
decrease over time as the quantity of insecticide active ingredient declines. The non-lethal protec-
tion provided by the LLIN may also decrease with the decay of the active ingredient and the physical
degradation of the net (i.e. the acquisition of holes). It is assumed that the underlying difference in
hut trial mortality between sites for standard LLINs is caused by the mosquito population having a
different population prevalence of pyrethroid resistance. Pyrethroid resistance may also influence
the relative strength of LLIN deterrence and exiting and it is important to characterise these modifi-
cations of behaviour as they contribute substantially to the population level impact of mass LLIN dis-
tribution. Visual inspection of these data indicates that mosquito deterrence and exiting can be
described by the degree of mosquito mortality seen in the same hut trial.
The proportion of mosquitoes not deterred from entering a hut by the LLIN is estimated using
mp, the ratio of the number of mosquitoes entering a hut with an LLIN (N1or N2) to the number enter-
ing a hut without a bednet (N0, here assumed to be the same as a hut with an untreated bed net). A
statistical model is used to determine whether there is an association between the number of mos-
quitoes entering a hut with a standard LLIN and the proportion of mosquitoes which die when they
do (which is assumed to be a proxy for mosquito susceptibility, i.e. m1 is described by l1 and m2 is
described by l2). It is assumed that the shape of the relationship between the proportion of
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mosquitoes entering a hut with an LLIN relative to a hut with an untreated net (1-deterrence) and
mortality is described by the flexible third order polynomial,
mp ¼ 1  d1þ d2 lp  t
  
þ d3 lp  t
  2h i
[8]
Np ~N mpN0;d4
  
[9]
Though there is no a priori reason to assume an inflection point in the relationship between mp and
lp the polynomial function is chosen as it is highly flexible and would allow such a curve should it exist
(which is necessary given the variability in the raw data). The shape parameters d1, d2 and d3 are esti-
mated assuming that the number of mosquitoes caught has a normal distribution (verified using a
and deterrence is allowed to vary at random between sites (with variance d4).
The proportion of mosquitoes entering the hut which exit without feeding is denoted jp whilst the
proportion which successfully feed upon entering is kp. Once entered the hut mosquitoes have to
either exit, die or successfully feed (i.e. 1 ¼ jp þ lp þ kp). Visual inspection of these data indicates that
kp increases with decreasing mortality at an exponential rate (Figure 3C). Therefore, if the number of
mosquitoes which feed and survive (Sp) follows a binomial distribution then,
Sp ~B kp;Np
  
þ  [10]
kp ¼ 1exp 2 1  lp  t
   
[11]
where 1 and 2 determine the shape of the relationship and  is a normally distributed random
error which varies between sites.
Parameterising transmission dynamics model
Estimates of jp, lp and mp can be used to determine the proportion of mosquitoes repeating (a com-
bination of deterrence and exiting, rp0), dying (dp0) and feeding successfully (sp0) during a single feed-
ing attempt in a hut with a new LLIN relative to those successfully feeding in a hut without an LLIN
(i.e. p=1 or 2),
rp0 ¼ 1 
k
0
p
k0
 !
j
0
p
j
0
pþ l
0
p
 !
[12]
dp0 ¼ 1 
k
0
p
k0
 !
l
0
p
j
0
pþ l
0
p
 !
[13]
sp0 ¼
k
0
p
k0
[14]
where jp ¼ 1  lp  kp, j
0
p ¼mpjpþ 1 mp
  
, k
0
p ¼mpkp and l
0
p ¼mplp (Griffin et al., 2010). Not all mosqui-
toes which enter a house will successfully feed even if there are no vector control interventions
inside. The experimental hut trials used in this analysis did not include a no-net control (k0) so histori-
cal studies are used for this parameter (Curtis et al., 1996; Lines et al., 1987). Though theoretically
sp0 could have values > 1 for practical purposes, it is constrained between zero and one as on aver-
age mosquitoes entering a hut with an LLIN are less likely to feed than a mosquito entering a hut
without a bednet (as shown by all estimates of kp being substantially lower than k0, see Figure 3C
and Table 6). The majority of experimental hut trials in M3 are in areas where the dominant vector is
A. gambiae s.s. and no studies were conducted in areas with A. funestus. As there is insufficient
information to generate these functions for each species separately it is assumed that the relation-
ship between rp0, sp0 and dp0 are consistent across all species. The average effectiveness of LLINs in
an entirely susceptible mosquito population identified in M3 is slightly higher than those analysed by
Griffin et al. (2010) which included a wider range of LLIN types. Values of mp (the propensity of
mosquitoes to enter a hut with an LLIN relative to one without) greater than one are truncated at
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one as there is insufficient evidence to justify that mosquitoes preferentially enter huts with LLINs (in
part because the number of studies with very low mortality are low and the metric has high measure-
ment error).
Decay in LLIN efficacy over time
The ability of a net to kill a mosquito will decrease over time as the quantity of insecticide active
ingredient declines. The non-lethal protection provided by the LLIN may also decrease with the
decay of the active ingredient and the physical degradation of the net (i.e. the acquisition of holes).
To fully capture the loss of efficacy of an LLIN requires a net durability survey to be carried out over
multiple years. To our knowledge, no durability studies have been published in areas of high pyre-
throid resistance nor using the new generation of LLINs with the addition of PBO. In the absence of
these data, we use the results from experimental hut trials that washed the net prior to its use. These
experimental huts give some indication of how mosquitoes react to the change in insecticide con-
centration, though they do not provide information on the physical durability of the net (as holes in
the net are artificially generated). For simplicity and following (Griffin et al., 2010) it is assumed that
Table 6. Parameter definitions and fitted values. Unless otherwise stated, all other parameters used were taken from Griffin et al.
(2010). Some parameters are mosquito species-specific whilst others are constant within a species complex (denoted *) or universal
(species independent $).
Parameter definitions
Anopheles
gambiae s.s.
Anopheles
arabiensis
Anopheles
funestus
x proportion mosquitoes dying in a discriminating dose pyrethroid bioassay -
I population prevalence of pyrethroid resistance (percentage survival) estimated using
x (Equation [1])
-
p net type under investigation in experimental hut trials: untreated (p ¼ 0); standard LLIN
(p ¼ 1); PBO LLIN (p ¼ 2).
-
dp probability a mosquito dies during single feeding attempt (Equation [18]) Estimated from parameters below
rp probability a mosquito exits the hut during single feeding attempt (Equation [17]) Estimated from parameters below
sp probability a mosquito feeds during single feeding attempt (Equation [19]) Estimated from parameters below
Np the number of mosquitoes entering a hut with net type p (Equation [3]) -
mp proportion of mosquitoes entering a hut with an LLIN to relative to a hut with an untreated
bed net (Np=N0, Equation [8])
$.
d1 = 0.071
d2 = 1.26
d3 = 1.52
lp proportion of mosquitoes that enter a hut with net type p that die (Equation [2])
$ a1 = 0.63
a2 = 4.00
kp proportion of mosquitoes that enter a hut with net type p that successfully feed and survive
(Equation [11])$
1 = 0.02
2 = 3.32
jp proportion of mosquitoes that enter a hut with net type p that exit without feeding 1  lp   kp
gp rate of decay in insecticide activity (in washes) for net type p (Equation [16])
$ p =  2.36
p =  3.05
f proportion of mosquitoes killed in pyrethroid + PBO bioassay (Equation [4])* b1 = 3.41, b2 = 5.88, b3 = 0.78 b1 = 2.53
b2 = 0.89
t constant used to centre the data to aid the fitting process 0.5
Relevant parameters previously estimated by Griffin et al. (2010)† and Walker et al. (2015)‡
k0 proportion of mosquitoes that enter a hut with no bednet that successfully feed
$ 0.70†
Hsy insecticide activity half-life in years for a susceptible mosquito population
$ 2.64†
rM proportion of mosquitoes which exit the hut when LLIN has no insecticidal activity 0.24
† 0.24‡ 0.24†
- mean life expectancy (days) 7.6† 7.6‡ 8.9†
- proportion blood meals taken on humans without LLINs (human blood index) 0.92† 0.71‡ 0.94†
- proportion of bites taken on humans whilst they are in bed 0.89† 0.83‡ 0.90†
DOI: 10.7554/eLife.16090.027
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the killing activity of pyrethroid over time (the half-life in years, denoted Hy) is proportional to the
loss of morbidity caused by washing (the half-life in washes, Hw). A prior estimate of the half-life in
years (Mahama et al., 2007) from a durability study of a non-PBO LLIN with susceptible mosquitoes
(Hsy) is then used to reflect changes caused by pyrethroid resistance by,
Hy ¼Hw=H
s
wH
s
y [15]
where superscript s indicates the half-life in a fully susceptible mosquito population (i.e. l1 = 1). Note
that if the newer PBO nets have better durability than standard LLINs then this will under estimate
their additional benefit. Following Griffin et al., 2010 it is assumed that the activity of the insecticide
decays at a constant rate according to a decay parameter gp, which is related to the half-life by
Hw ¼ ln 2ð Þ=gp. To test whether the rate of decay changes with lp (i.e. mosquito mortality caused by
new standard and PBO LLINs) the following equation was fit to M3,
logit gp
  
¼ pþ p lp  t
  
: [16]
Shape parameters p and p are allowed to vary between net types. The proportion of mosquitoes
repeating due to the LLIN decreases from a maximum, rp0, to a non-zero level rM , reflecting the pro-
tection still provided by an LLIN that no longer has any insecticidal activity. For simplicity, it is
assumed that the rate of decay from rp0 to rM is given by gp (as the degradation of the net over time
is unlikely to be recreated by washing). The full equations for the proportion of mosquitoes repeat-
ing, dying and successfully feeding at time t following LLIN distribution (rp, dp and sp, respectively) is
given by,
rp ¼ rp0  rM
  
exp  gpt
  
þ rM [17]
dp ¼ dp0 exp  gpt
  
[18]
sp ¼ 1  rp  dp: [19]
Fitting procedure
All models were fit using a Markov chain Monte Carlo sampling algorithm implemented in the pro-
gramme OPENBUGS (Lunn et al., 2009). This Bayesian method enabled measurement error to be
incorporated in both the dependent and independent variables according to the number of mosqui-
toes sampled (both in bioassays and hut trials). Uninformative priors were used for all parameters
with the exception of the random effects variance parameters which were constrained to be positive
(though were still uninformative,see Source code 1 in the Supplementary Information for a full list of
priors). Three Markov chains were initialized to assess convergence and the first 5000 Markov chain
Monte Carlo iterations were discarded as burn in. Convergence was assessed visually and a total of
10,000 iterations were used to derive the posterior distribution for all parameters and to generate
95% Bayesian credible interval estimates for model fits. The models were compared using the devi-
ance information criterion (DIC) where the smaller value indicates a better fit, and a difference of five
deviance information criterion units is considered to be substantial (Spiegelhalter et al., 2002).
Equations [8] to [19] were fit simultaneously to M3 enable the impact of washed nets to contribute
to the relationship between rp, dp and sp, through the decay function, gp, doubling the number of
datapoints in the analysis. A direct comparison between net types is beyond the scope of this study.
Only one study compared PermaNet 2.0 and PermaNet 3.0 at the same time and place as Olyset
and Olyset Plus and this study did not conduct hut trials with washed LLINs. As the different nets
were tested in areas with different levels of pyrethroid resistance (in part because the low overall
number of studies) then the impact of resistance and net type cannot currently be disentangled.
Predicting the public health impact of insecticide resistance
The public health benefit of PBO-LLINs will depend on the epidemiological setting in which they are
deployed. This includes the baseline characteristics of the setting (e.g. mosquito species, abundance
and seasonality), history of malaria control interventions (e.g. prior use of bednets, management of
clinical cases) and prevalence of insecticide resistance. The rate at which pyrethroid resistance has
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evolved is highly uncertain. It is likely that it first became evident through its use in agriculture and
the relative contribution of vector control to the selection of resistance is unknown and will vary
between sites. This makes it impossible to recreate the spread of resistant phenotypes in a particular
setting and predict its cumulative public health impact without detailed longitudinal studies span-
ning decades (which do not exist for malaria endemic regions). Instead the impact of pyrethroid
resistance is estimated by assuming it arrives instantaneously at a given level. To generate a broadly
realistic history of LLIN usage it is assumed that LLINs were introduced at a defined coverage at year
zero and redistributed every three years to the same percentage of the human population (Figure 1).
The mosquito population is assumed to be either A. gambiae s.s., A. arabiensis or Anopheles funes-
tus (the three major vectors in Africa) which are entirely susceptible to pyrethroids up until year 6
when pyrethroid resistance arrives instantaneously. The public health impact of resistance is then
measured over the subsequent three years (the average clinical incidence or entomological inocula-
tion rate (EIR) between the years 6 and 9) and compared to a population where resistance did not
arise. The impact of PBO LLINs is predicted by introducing them into the resistant population at
the year 9 and then measuring over the subsequent 3 years. For simplicity, it is assumed that there is
perennial transmission, no other type of vector control and that once introduced pyrethroid resis-
tance remains constant. Though perennial transmission is unrealistic it is necessary in order to pro-
duce simple guidelines (as there is a very high number of combinations of seasonal patterns, relative
mosquito species abundance and timings of LLIN distribution campaigns). A sensitivity analysis with
more realistic seasonal patterns shows the change in clinical incidence compared to the perennial
transmission is relatively minor, in part because the LLINs are used over 3 yearly cycles and their
decay in effectiveness is relatively slow. LLINs are initially distributed at time zero at random (i.e.
there was no targeting to those with the highest infection) and from then on the same people
receive them every campaign to ensure that coverage remains at the defined level (i.e. the number
of people with an LLIN would go up if the distribution was random each round). Realistic usage pat-
terns are adopted to reflect higher coverage immediately after LLIN distribution. No other vector
control is incorporated whilst 35% of clinical cases are assumed to receive treatment, 36% which
receive an ACT (estimated by averaging across Africa using data collated by Cohen et al., [2012]). A
full list of the parameters, their definitions and estimated values are given in Table 6 whilst all other
parameters are taken from Griffin et al. (2010) and White et al. (2011).
To investigate how the uncertainty in mosquito behaviour and the impact of PBO influence model
predictions, a full sensitivity analysis is carried out for the parameters determining LLIN efficacy. A
thousand parameter sets for a1, a2, b1;b2;, d1, d2, 1, 2, p and p are sampled from the posterior
distribution and are used to generate a range of possible values for rp0, sp0, dp0 and gp (Figure 4—
figure supplement 5). This allows uncertainty in all measurements (such as the relationship between
resistance and hut trial mortality) to be propagated throughout the equations. These parameter sets
are then included as runs within the full transmission dynamics model to unsure the full uncertainty in
these data is represented and the 95% credible intervals for model outputs are then shown.
Source data
Figure 2—source data 1–3. Figure 2—source data 4 is hosted on Dryad (doi: 10.5061/dryad.13qj2)
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